Log in

OTCMKTS:THERFTheratechnologies Stock Price, Forecast & News

$1.80
-0.22 (-10.89 %)
(As of 06/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.79
Now: $1.80
$2.05
50-Day Range
$1.53
MA: $2.70
$3.80
52-Week Range
$3.58
Now: $1.80
$7.29
Volume268,939 shs
Average Volume25,677 shs
Market Capitalization$138.51 million
P/E RatioN/A
Dividend YieldN/A
Beta0.58
Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States. The company was founded in 1993 and is headquartered in Montreal, Canada.
Read More
Theratechnologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.08 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:THERF
Previous SymbolNASDAQ:THER
CUSIPN/A
CIKN/A
Phone514-336-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$45.18 million
Cash Flow$0.01 per share
Book Value$0.47 per share

Profitability

Net Income$-4,660,000.00

Miscellaneous

Employees32
Market Cap$138.51 million
Next Earnings DateN/A
OptionableNot Optionable

Receive THERF News and Ratings via Email

Sign-up to receive the latest news and ratings for THERF and its competitors with MarketBeat's FREE daily newsletter.

Theratechnologies (OTCMKTS:THERF) Frequently Asked Questions

How has Theratechnologies' stock been impacted by COVID-19 (Coronavirus)?

Theratechnologies' stock was trading at $2.91 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, THERF shares have decreased by 38.1% and is now trading at $1.80. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Theratechnologies?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Theratechnologies.

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc (OTCMKTS:THERF) released its earnings results on Thursday, April, 4th. The company reported $0.01 earnings per share for the quarter, meeting analysts' consensus estimates of $0.01. The business earned $15.10 million during the quarter. Theratechnologies had a negative net margin of 11.57% and a negative return on equity of 14.31%. View Theratechnologies' earnings history.

What price target have analysts set for THERF?

2 brokerages have issued twelve-month price objectives for Theratechnologies' shares. Their forecasts range from $6.00 to $6.00. On average, they anticipate Theratechnologies' share price to reach $6.00 in the next twelve months. This suggests a possible upside of 233.3% from the stock's current price. View analysts' price targets for Theratechnologies.

Has Theratechnologies been receiving favorable news coverage?

News stories about THERF stock have trended very positive on Tuesday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Theratechnologies earned a coverage optimism score of 3.5 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutTheratechnologies.

Who are some of Theratechnologies' key competitors?

Who are Theratechnologies' key executives?

Theratechnologies' management team includes the following people:
  • Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)
  • Mr. Philippe Dubuc MBA, Sr. VP & CFO (Age 52)
  • Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)
  • Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53)
  • Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)

What is Theratechnologies' stock symbol?

Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF."

How do I buy shares of Theratechnologies?

Shares of THERF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Theratechnologies' stock price today?

One share of THERF stock can currently be purchased for approximately $1.80.

How big of a company is Theratechnologies?

Theratechnologies has a market capitalization of $138.51 million and generates $45.18 million in revenue each year. Theratechnologies employs 32 workers across the globe.

What is Theratechnologies' official website?

The official website for Theratechnologies is www.theratech.com.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The company can be reached via phone at 514-336-7800 or via email at [email protected]

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.